CA-NETAPP
14.5.2024 14:02:00 CEST | Business Wire | Press release
NetApp® (NASDAQ: NTAP), the intelligent data infrastructure company, today announced NetApp AIPod with Lenovo ThinkSystem servers for NVIDIA OVX, a converged infrastructure optimized for the generative AI era. NetApp and Lenovo have had a strong partnership for over five years and are now taking the partnership to the next level with the introduction of this simple, cost-effective, and powerful solution for enterprise AI. The new converged infrastructure solution will support NVIDIA NIM inference microservices, the NVIDIA AI Enterprise software platform for generative AI development and deployment, and retrieval-augmented generation (RAG) to enable customers to leverage their private, proprietary data for AI without large-scale model training.
Generative AI has created extensive opportunities for organizations, though many may feel as if AI is out of reach due to the cost, integration complexity, and time to deployment. Meanwhile, pre-built large language models (LLMs) often do not have training on the most up-to-date or relevant data organizations need to generate valuable insights or effectively automate routine tasks.
NetApp has led in unstructured data storage for over three decades, and much of the world’s enterprise unstructured data is stored in NetApp storage. Unlocking the full value of this data requires going far beyond foundational model training. By enabling inferencing and RAG, the NetApp AIPod with Lenovo’s leading server reliability, quality, and performance makes it seamless, simple, and fast to combine the power of LLMs with precise, up-to-date, and pertinent information on NetApp storage.
"The NetApp AIPod with Lenovo ThinkSystem servers for NVIDIA OVX transforms enterprise AI by delivering a pre-integrated, high-performance solution that accelerates the deployment and scaling of generative AI workloads," said Sandeep Singh, Senior Vice President & General Manager, Enterprise Storage at NetApp. "Through our collaboration with NVIDIA and Lenovo, NetApp is empowering organizations to harness the capabilities of AI more efficiently, ensuring that they can focus on creating value and gaining insights from their data without the complexity of building and managing AI infrastructure from scratch."
NetApp AIPod combines NetApp's robust storage systems with hybrid cloud data management, including Lenovo's high-performance ThinkSystem SR675 V3 servers, the leading platforms supporting NVIDIA-certified OVX architecture with NVIDIA L40S GPUs, as well as NVIDIA Spectrum-X Networking, providing a complete and seamless infrastructure solution to streamline AI adoption. Using this solution, customers will be able to conduct AI RAG and inferencing operations for use cases like chatbots, knowledge management, and object recognition. NetApp, in collaboration with Lenovo and NVIDIA, simplifies AI deployment by seamlessly integrating into ecosystems, simplifying operations, accelerating implementation, and safeguarding AI infrastructure, enabling organizations to unlock AI's full potential.
“Lenovo is expanding our partnership with NetApp and NVIDIA to bring the power of AI to every business as part of our continued commitment to enabling and simplifying hybrid AI for our joint customers,” said Kirk Skaugen, President of Lenovo Infrastructure Solutions Group. “As customers deploy AI, they demand business critical availability, ease of management, and infrastructure efficiency. The NetApp AIPod with Lenovo ThinkSystem servers for NVIDIA OVX delivers optimized and validated solutions to make generative AI more accessible for businesses of every size.”
“Making AI accessible and scalable for every industry is more important than ever,” said Bob Pette, Vice President of Enterprise Platforms at NVIDIA. “The NetApp AIPod with Lenovo for NVIDIA OVX offers an AI-ready platform that’s powerful and easy to use, enabling businesses to drive innovation.”
NetApp AIPod with Lenovo for NVIDIA OVX will be available by summer 2024.
Additional Resources
- NetApp AIPodTM with Lenovo for NVIDIA OVX: The Power of Retrieval-Augmented Generation for Every Enterprise
- NetApp Unveils Unified Data Storage Built for the AI Era
- AIPod: Delivering the Promise
About NetApp
NetApp is the intelligent data infrastructure company, combining unified data storage, integrated data services, and CloudOps solutions to turn a world of disruption into opportunity for every customer. NetApp creates silo-free infrastructure, harnessing observability, and AI to enable the industry’s best data management. As the only enterprise-grade storage service natively embedded in the world’s biggest clouds, our data storage delivers seamless flexibility. In addition, our data services create a data advantage through superior cyber resilience, governance, and application agility. Our CloudOps solutions provide continuous optimization of performance and efficiency through observability and AI. No matter the data type, workload, or environment, with NetApp you can transform your data infrastructure to realize your business possibilities. Learn more at www.netapp.com or follow us on X, LinkedIn, Facebook, and Instagram.
NETAPP, the NETAPP logo, and the marks listed at www.netapp.com/TM are trademarks of NetApp, Inc. Other company and product names may be trademarks of their respective owners.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240514466001/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Phase 3 RAINIER Results Supporting Best-in-Class Potential of Povetacicept in IgA Nephropathy Published in the New England Journal of Medicine and Presented at the American Society of Nephrology Kidney Week 202623.10.2026 19:42:00 CEST | Press release
- Vertex is on track for the U.S. FDA Prescription Drug User Fee Act (PDUFA) date of November 30 for potential accelerated approval of povetacicept –- Data published in NEJM and presented at ASN highlight povetacicept’s unique trifecta of efficacy, favorable safety, and the simplicity of dosing at-home every 4 weeks with a low-volume autoinjector –- Data presented at ASN include a qualitative study examining patient perspectives on current and emerging IgAN therapies, showing that 96% of participants preferred an autoinjector over a prefilled syringe, and 80% of participants preferred dosing every 4 weeks versus weekly dosing - - New clinical studies of povetacicept underway including a study evaluating patient experience on povetacicept administered via autoinjector - Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced the publication of Phase 3 RAINIER results for povetacicept in the New England Journal of Medicine (NEJM), presentation of these data at the American Soc
BeOne Medicines Reports Sustained Survival Benefit with TEVIMBRA-ZIIHERA Combination in First-Line HER2+ Gastroesophageal Cancer23.10.2026 16:15:00 CEST | Press release
New data from HERIZON-GEA-01 Phase 3 trial show 36-month overall survival of nearly 40% with TEVIMBRA plus ZIIHERA and chemotherapy, and median OS reaching 27 monthsTEVIMBRA-containing arm was associated with a four-month longer median OS compared with ZIIHERA plus chemotherapy BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new survival results from the planned second interim analysis (IA2) and final formal analysis of the Phase 3 HERIZON-GEA-01 trial, further confirming the benefit of TEVIMBRA® (tislelizumab) plus ZIIHERA® (zanidatamab) and chemotherapy as first-line treatment for patients with HER2-positive locally advanced or metastatic gastroesophageal adenocarcinoma (GEA). The results will be presented today as a late-breaking abstract during a rapid oral session at the European Society for Medical Oncology (ESMO) Congress 2026 in Madrid, Spain (LBA79). Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne,
Lifezone Metals Confirms Advanced Negotiations with Orion CMC on Kabanga Nickel Project23.10.2026 16:10:00 CEST | Press release
Lifezone Metals Limited (NYSE: LZM) notes comments made today by Oskar Lewnowski, Founder and Group Chief Executive of Orion Resource Partners, in an interview with Bloomberg Television regarding the Company’s Kabanga Nickel Project in Tanzania. In response to inbound inquiries from media outlets and investors following the interview, the Company can confirm that negotiations with Orion Critical Mineral Consortium (Orion CMC) regarding a significant equity investment into the Kabanga Nickel Project are at an advanced stage. The Orion CMC is a global investment platform launched by Orion Resource Partners in partnership with the U.S. International Development Finance Corporation (DFC) and Abu Dhabi's sovereign investor ADQ. As previously announced, the Company has been running a competitive process, led by Standard Chartered Bank, to secure a strategic investment into the Kabanga Nickel Project. Social Media LinkedIn | X | YouTube About Lifezone Metals Lifezone Metals (NYSE: LZM) is com
inDrive and Pony.ai Announce Collaboration to Explore Autonomous Mobility in Kazakhstan Built on NVIDIA Hyperion23.10.2026 15:00:00 CEST | Press release
Collaboration will establish the roadmap for bringing Pony.ai robotaxis to Kazakhstan on the inDrive ride-hailing platform, leveraging the NVIDIA Hyperion and the NVIDIA Halos safety system. inDrive, the global mobility and delivery platform, today announced it has signed a memorandum of understanding (MOU) with NVIDIA and Pony.ai, a global leader in the large-scale commercialization of autonomous driving technology, to explore the future of autonomous ride-hailing. Kazakhstan will serve as the first test market. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261023143469/en/ inDrive partners with Pony.ai and NVIDIA to explore autonomous mobility in Kazakhstan Kazakhstan was chosen first for its regulatory readiness following the creation of the country’s first structured legal framework for driverless transport, as part of its “Year of Digitalization and Artificial Intelligence.” Combined with Kazakhstan’s position as a lea
Brenus Pharma's Novel In Vivo Immunotherapy STC-1010 Shows Safety, Activating T Cells in First-Line MSS Metastatic Colorectal Cancers With 2 Complete Responses.23.10.2026 14:50:00 CEST | Press release
Phase Ia BreAK CRC-001 at ESMO 2026: 43% of patients, all initially unresectable, became eligible for surgery Poster 1023P – Developmental Therapeutics Brenus Pharma, a clinical-stage biotech company, announced first data from the Phase Ia dose escalation of BreAK CRC-001. Nine unresectable patients were treated; 89% had liver metastases and 89% KRAS-mutant tumors, a population refractory to immunotherapy. Median follow-up: 8 months (1–14; data cut-off 6/08/2026). 95% of metastatic colorectal cancers are pMMR/MSS tumors, poorly immunogenic and resistant to immunotherapy. STC-1010, the company’s lead in vivo DC-engager, is designed to make these “cold” tumors visible to immune cells. Safety: no dose-limiting toxicity, only grade 1–2 related adverse events. Clinical activity (seven evaluable patients, RECIST 1.1): 100% disease control, 57% objective response rate (4/7). 43% of patients became operable (3/7): two with no evidence of disease afterward. Molecular profile: ctDNA dropped by u
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
